Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermLiab,longTermInvestments,shortTermInvestments,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,effectOfExchangeRate,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,esgPopulated,tradeable,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,shortName,exchange,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry
t0,V3V.DE,-2545000.0,4098150,,,282000,-17000,-38000,2326000,3199000,311000,311000,562000,-43000,,,,319000,5379000,5068000,2180000,-29000,,-37000,-38000,13739000.0,29440000.0,29517000.0,4853000.0,58940000.0,4146000.0,1000.0,1814000.0,17807000.0,18323000.0,23557000.0,2360000.0,10813000.0,8815000.0,1534000.0,23818000.0,9024000.0,15494000.0,4350000.0,1915000.0,330000.0,1838000.0,,,,99000.0,85000.0,-101000.0,-529000.0,-530000.0,613000.0,417000.0,1047000.0,737000.0,3000.0,42000.0,-571000.0,-1000.0,179000.0,-203000.0,,6679000.0,en-US,US,EQUITY,False,Delayed Quote,-1.9230781,15.3 - 15.45,15.6,15.0,15.35,450,250,finmb_10838013,XETRA,VITA 34 AG,EUR,3038,2027,4.7,0.44339618,10.6 - 17.95,-2.6500006,-0.14763233,10.6,17.95,EUR,False,False,de_market,15.3,1630578030,-0.3000002,15.45,15.45,15.3,1413,REGULAR,VITA 34 AG NA O.N.,GER,1617101940,1617101940,1617101940,0.16,50.32895,0.01025641,0.304,0,7.203,15.712857,-0.41285706,-0.02627511,15.714437,-0.41443634,-0.02637297,62701696,2.124115,15,Europe/Berlin,CEST,7200000,2,1.17,,,17.95,10.6,15.71,15.71,3.04k,2.03k,4.1M,,536.33k,40.89%,8.57%,,,,,,,,0.16,1.03%,,0.00%,,"Jun 05, 2019",,,"Dec 31, 2020","Mar 31, 2021",5.94%,12.76%,2.77%,4.07%,20.81M,5.12,16.10%,11.66M,5.04M,1.24M,0.30,,10.81M,2.64,4.94M,16.75,1.76,7.20,4.34M,3.76M,Value,04103,Healthcare,120,"VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",Leipzig,49 341 48792 0,1609372800,Germany,http://www.vita34.de,86400,Deutscher Platz 5a,49 341 48792 20,Medical Care Facilities
t-1,V3V.DE,-2616000.0,4098150,,,-182000,-18000,-340000,2324000,2522000,204000,204000,-6000,-43000,,,,177000,5045000,4841000,2523000,-386000,,-359000,-340000,13846000.0,28929000.0,29553000.0,4237000.0,58464000.0,4146000.0,452000.0,1852000.0,17762000.0,18323000.0,23555000.0,2501000.0,10396000.0,7913000.0,1493000.0,23816000.0,8911000.0,14644000.0,3305000.0,2273000.0,372000.0,1318000.0,384000.0,239000.0,119000.0,99000.0,328000.0,-165000.0,-530000.0,-813000.0,-196000.0,-123000.0,855000.0,1078000.0,1000.0,-11000.0,130000.0,-283000.0,-180000.0,-164000.0,1000.0,6731000.0,en-US,US,EQUITY,False,Delayed Quote,-1.9230781,15.3 - 15.45,15.6,15.0,15.35,450,250,finmb_10838013,XETRA,VITA 34 AG,EUR,3038,2027,4.7,0.44339618,10.6 - 17.95,-2.6500006,-0.14763233,10.6,17.95,EUR,False,False,de_market,15.3,1630578030,-0.3000002,15.45,15.45,15.3,1413,REGULAR,VITA 34 AG NA O.N.,GER,1617101940,1617101940,1617101940,0.16,50.32895,0.01025641,0.304,0,7.203,15.712857,-0.41285706,-0.02627511,15.714437,-0.41443634,-0.02637297,62701696,2.124115,15,Europe/Berlin,CEST,7200000,2,1.17,,,17.95,10.6,15.71,15.71,3.04k,2.03k,4.1M,,536.33k,40.89%,8.57%,,,,,,,,0.16,1.03%,,0.00%,,"Jun 05, 2019",,,"Dec 31, 2020","Mar 31, 2021",5.94%,12.76%,2.77%,4.07%,20.81M,5.12,16.10%,11.66M,5.04M,1.24M,0.30,,10.81M,2.64,4.94M,16.75,1.76,7.20,4.34M,3.76M,Value,04103,Healthcare,120,"VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",Leipzig,49 341 48792 0,1609372800,Germany,http://www.vita34.de,86400,Deutscher Platz 5a,49 341 48792 20,Medical Care Facilities
t-2,V3V.DE,-3779000.0,4098150,,,1107000,123000,745000,2258000,3391000,1140000,1140000,-7000,-44000,,,,357000,5424000,4284000,2033000,-33000,,750000,745000,17473000.0,29311000.0,32017000.0,4782000.0,61451000.0,4146000.0,,4290000.0,17515000.0,18323000.0,23581000.0,2203000.0,10519000.0,8098000.0,1534000.0,23842000.0,8928000.0,14524000.0,3644000.0,2673000.0,361000.0,1259000.0,,,,99000.0,129000.0,-179000.0,-525000.0,-523000.0,-100000.0,581000.0,1283000.0,622000.0,17000.0,35000.0,-228000.0,2000.0,79000.0,-178000.0,1000.0,6426000.0,en-US,US,EQUITY,False,Delayed Quote,-1.9230781,15.3 - 15.45,15.6,15.0,15.35,450,250,finmb_10838013,XETRA,VITA 34 AG,EUR,3038,2027,4.7,0.44339618,10.6 - 17.95,-2.6500006,-0.14763233,10.6,17.95,EUR,False,False,de_market,15.3,1630578030,-0.3000002,15.45,15.45,15.3,1413,REGULAR,VITA 34 AG NA O.N.,GER,1617101940,1617101940,1617101940,0.16,50.32895,0.01025641,0.304,0,7.203,15.712857,-0.41285706,-0.02627511,15.714437,-0.41443634,-0.02637297,62701696,2.124115,15,Europe/Berlin,CEST,7200000,2,1.17,,,17.95,10.6,15.71,15.71,3.04k,2.03k,4.1M,,536.33k,40.89%,8.57%,,,,,,,,0.16,1.03%,,0.00%,,"Jun 05, 2019",,,"Dec 31, 2020","Mar 31, 2021",5.94%,12.76%,2.77%,4.07%,20.81M,5.12,16.10%,11.66M,5.04M,1.24M,0.30,,10.81M,2.64,4.94M,16.75,1.76,7.20,4.34M,3.76M,Value,04103,Healthcare,120,"VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",Leipzig,49 341 48792 0,1609372800,Germany,http://www.vita34.de,86400,Deutscher Platz 5a,49 341 48792 20,Medical Care Facilities
t-3,V3V.DE,-4872000.0,4098150,,,832000,118000,741000,2103000,2979000,833000,833000,43000,-46000,,,,91000,4927000,4094000,1948000,-1000,,741000,741000,17818000.0,29829000.0,31269000.0,4718000.0,61216000.0,4146000.0,1000.0,3545000.0,17510000.0,18323000.0,23578000.0,2043000.0,9938000.0,8138000.0,1534000.0,23839000.0,8994000.0,14038000.0,3703000.0,3048000.0,396000.0,1351000.0,,,,370000.0,-31000.0,200000.0,-524000.0,-524000.0,240000.0,827000.0,1151000.0,609000.0,2000.0,-50000.0,-74000.0,2000.0,-283000.0,-153000.0,1000.0,5900000.0,en-US,US,EQUITY,False,Delayed Quote,-1.9230781,15.3 - 15.45,15.6,15.0,15.35,450,250,finmb_10838013,XETRA,VITA 34 AG,EUR,3038,2027,4.7,0.44339618,10.6 - 17.95,-2.6500006,-0.14763233,10.6,17.95,EUR,False,False,de_market,15.3,1630578030,-0.3000002,15.45,15.45,15.3,1413,REGULAR,VITA 34 AG NA O.N.,GER,1617101940,1617101940,1617101940,0.16,50.32895,0.01025641,0.304,0,7.203,15.712857,-0.41285706,-0.02627511,15.714437,-0.41443634,-0.02637297,62701696,2.124115,15,Europe/Berlin,CEST,7200000,2,1.17,,,17.95,10.6,15.71,15.71,3.04k,2.03k,4.1M,,536.33k,40.89%,8.57%,,,,,,,,0.16,1.03%,,0.00%,,"Jun 05, 2019",,,"Dec 31, 2020","Mar 31, 2021",5.94%,12.76%,2.77%,4.07%,20.81M,5.12,16.10%,11.66M,5.04M,1.24M,0.30,,10.81M,2.64,4.94M,16.75,1.76,7.20,4.34M,3.76M,Value,04103,Healthcare,120,"VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",Leipzig,49 341 48792 0,1609372800,Germany,http://www.vita34.de,86400,Deutscher Platz 5a,49 341 48792 20,Medical Care Facilities
